News for hackers. Stuff that matters.

A comment on FDA promised a ‘lower-cost option’ to EpiPen, but the price isn’t any lower. Parent comment

Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by r00fus on Wednesday November 28, 2018 @05:58PM (#18556490)
Cue pharma & equipment companies complaining about R&D costs for patents and approval processes.

Of course, they still complain and somehow shoehorn busdev & marketing costs into the R&D bucket anyway.

[ Parent | on HN ]
Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by TheSpiceIsLife on Wednesday November 28, 2018 @07:27PM (#18557066)
What R&D costs are there for existing, well established, proven emergency medicines for their current uses?
[ Parent | on HN ]